Hypogonadotropic Hypogonadism 2 With Or Without Anosmia; Hh2
Description
Congenital idiopathic hypogonadotropic hypogonadism (IHH) is a disorder characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone and no other abnormalities of the hypothalamic-pituitary axis. Idiopathic hypogonadotropic hypogonadism can be caused by an isolated defect in gonadotropin-releasing hormone (GNRH ) release, action, or both. Other associated nonreproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss, occur with variable frequency. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism has been called 'Kallmann syndrome (KS),' whereas in the presence of a normal sense of smell, it has been termed 'normosmic idiopathic hypogonadotropic hypogonadism (nIHH)' (summary by Raivio et al., 2007). Because families have been found to segregate both KS and nIHH, the disorder is here referred to as 'hypogonadotropic hypogonadism with or without anosmia (HH).'Although HH was initially considered to be a monogenic disorder, the presence of marked locus heterogeneity, incomplete penetrance within pedigrees, and variable expressivity of pathogenic alleles, together with evidence for mutations in multiple genes in some affected individuals, resulted in a conceptual shift from monogenicity to an oligogenic framework in which a limited number of genes contribute pathogenic alleles to the genetic network responsible for the neuroendocrine control of human reproduction (Sykiotis et al., 2010).
Genes related to Hypogonadotropic Hypogonadism 2 With Or Without Anosmia; Hh2
- FGFR1
Clinical Features
Top most frequent phenotypes and symptoms related to Hypogonadotropic Hypogonadism 2 With Or Without Anosmia; Hh2
- Intellectual disability
- Short stature
- Hearing impairment
- Neoplasm
- Sensorineural hearing impairment
- Cleft palate
- Cryptorchidism
- Abnormality of cardiovascular system morphology
- Clinodactyly
- Agenesis of corpus callosum
And another 32 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Hypogonadotropic Hypogonadism 2 With Or Without Anosmia; Hh2 Is also known as kallmann syndrome 2, kal2.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Hypogonadotropic Hypogonadism 2 With Or Without Anosmia; Hh2 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
FGFR1 DNA Sequencing Test.
By Athena Diagnostics Inc (United States).
FGFR1
Specificity
100 %
Genes
100 % |
Normosmic Kallmann/IHH Evaluation.
By Athena Diagnostics Inc (United States).
TACR3, PROKR2, PROK2, FGFR1, GNRH1, GNRHR, KISS1R
Specificity
15 %
Genes
100 % |
Anosmic Kallmann/IHH Evaluation.
By Athena Diagnostics Inc (United States).
PROKR2, PROK2, FGF8, FGFR1, GNRHR, KISS1R, ANOS1
Specificity
15 %
Genes
100 % |
Complete Kallmann/IHH Evaluation.
By Athena Diagnostics Inc (United States).
TACR3, PROKR2, PROK2, CHD7, FGF8, FGFR1, GNRH1, GNRHR, KISS1R, ANOS1
Specificity
10 %
Genes
100 % |
Hearing Loss Advanced Sequencing and CNV Evaluation.
By Athena Diagnostics Inc (United States).
BCS1L, ROR1, SALL1, SEMA3E, SIX1, SIX5, SLC12A1, SLC19A2, SLC22A4, SNAI2, SMPX, SOX10, TBX1, TCOF1, TECTA, TFAP2A, TIMM8A, TJP2, TMPRSS3, USH1C , (...)
View the complete list with 149 more genes
Specificity
1 %
Genes
100 % |
NGS Craniosynostosis Panel.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
TWIST1, RAB23, FGFR1, FGFR2, MSX2, POR, RECQL4
Specificity
15 %
Genes
100 % |
FGFR1-Related Disorders - FGFR1 Sequencing.
By Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado (United States).
FGFR1
Specificity
100 %
Genes
100 % |
FGFR1-Related Disorders - Del/Dup Analysis.
By Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado (United States).
FGFR1
Specificity
100 %
Genes
100 % |
You can get up to 173 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1; VAMAS1 MYOPATHY, MYOFIBRILLAR, 5; MFM5